TG THERAPEUTICS, INC. Quarterly Costs and Expenses in USD from Q3 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Tg Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2022 to Q3 2024.
  • Tg Therapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $71.4M, a 40% increase year-over-year.
  • Tg Therapeutics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $265M.
  • Tg Therapeutics, Inc. annual Costs and Expenses for 2023 was $213M, a 8.9% increase from 2022.
  • Tg Therapeutics, Inc. annual Costs and Expenses for 2022 was $196M, a 44.3% decline from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $265M $71.4M +$20.4M +40% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $245M $64.7M +$3.9M +6.42% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $241M $72.7M +$27.9M +62.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $213M $56.5M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $51M +$16M +45.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $60.7M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $44.8M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q3 2022 $35.1M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.